To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to report on whether the Secretary will include certain psychedelic drugs in the formulary of the Department of Veterans Affairs.
This bill requires the Department of Veterans Affairs (VA), when a psychedelic drug is approved or licensed by the Food and Drug Administration, to report on the VA's decision whether to include the drug in its formulary and the justification for such decision.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Veterans' Affairs.
Referred to the Subcommittee on Health.
Subcommittee Hearings Held
Forwarded by Subcommittee to Full Committee by Voice Vote.
Subcommittee Consideration and Mark-up Session Held
Ordered to be Reported by Voice Vote.
Committee Consideration and Mark-up Session Held
Placed on the Union Calendar, Calendar No. 544.
Reported by the Committee on Veterans' Affairs. H. Rept. 118-647.
Introduced in House
Referred to the House Committee on Veterans' Affairs.
Referred to the Subcommittee on Health.
Subcommittee Hearings Held
Forwarded by Subcommittee to Full Committee by Voice Vote.
Subcommittee Consideration and Mark-up Session Held
Ordered to be Reported by Voice Vote.
Committee Consideration and Mark-up Session Held
Placed on the Union Calendar, Calendar No. 544.
Reported by the Committee on Veterans' Affairs. H. Rept. 118-647.
Armed Forces and National Security
Alternative treatmentsCongressional oversightDrug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesPrescription drugs
To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to report on whether the Secretary will include certain psychedelic drugs in the formulary of the Department of Veterans Affairs.
USA118th CongressHR-7347| House
| Updated: 9/6/2024
This bill requires the Department of Veterans Affairs (VA), when a psychedelic drug is approved or licensed by the Food and Drug Administration, to report on the VA's decision whether to include the drug in its formulary and the justification for such decision.
Alternative treatmentsCongressional oversightDrug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesPrescription drugs